Chronic Kidney Disease Care in Saudi Arabia: Challenges, and Future Directions Under Vision 2030 (A Systematic Review Study) Authors: Abdulaziz Backer Albacker Published: 2026 ABSTRACT AbstractThe increasing healthcare burden from kidney disease which includes chronic kidney disease (CKD) and end-stage kidney disease (ESKD) demonstrates how diabetes and hypertension have become major health concerns for the Saudi Arabian population. The review examines Saudi Vision 2030 through its current epidemiological data and healthcare system assessment and existing obstacles to effective treatment and potential future developments. A literature search identified key studies on prevalence, risk factors, workforce, and innovations. The population screening results shows that CKD prevalence ranges from 4.76% to 13.8% with diabetic nephropathy and hypertensive nephropathy as the main causes. Although nephrologist density reaches approximately 39 doctors per million residents in certain areas, both regional disparities and workforce training deficits remain active issues. The system faces multiple difficulties which include delayed patient referrals, inadequate use of home treatment options, financial constraints and variable patient access to transplantation procedures and advanced diagnostic methods. The field of medicine will experience major changes through new developments which include fresh biomarkers and artificial intelligence (AI)-based risk assessment tools and telemedicine and personalized medical solutions. The implementation of prevention measures along with early detection programs and multidisciplinary treatment methods and digital health solutions will help achieve sustainable and fair kidney care. The review presents specific steps which will help decrease disease rates and death rates and financial costs while advancing the health transformation objectives established in Vision 2030.Keywords: chronic kidney disease, Saudi Arabia, vision 2030 Introduction Kidney disease causes major health problems and financial costs throughout the world because chronic kidney disease affects 850 million people. The combination of urbanization and changing socio-economic conditions and increasing rates of non-communicable diseases has caused kidney disease to become more common in Saudi Arabia. Diabetes mellitus affects ≈18–20% of the adult population, and hypertension ≈26%, both major drivers of CKD and ESKD.1 Population-based research shows that 4.76% of people have chronic kidney disease and stage 3 is the most common type at 3.5%. The condition occurs more frequently in males at 5.83% compared to 3.88% in females and it becomes more common as people grow older until it affects over half of those who reach 90 years.2 Family screening studies of first-degree relatives of dialysis patients reveal even higher rates (13.8%), underscoring genetic and shared environmental risks.3 The age-standardized prevalence of CKD stages 1–5 (excluding renal replacement therapy (RRT)) is estimated at 9892 per 100,000, exceeding figures for Western Europe and North America in some projections.4 ESKD care relies heavily on kidney replacement therapy (KRT). More than 20000 patients receive dialysis treatment while approximately 9810 patients have a functioning kidney transplant; the total renal replacement therapy (RRT) cases reach about 294 per million populations.5 Hemodialysis remains the dominant modality approximately 67 to 90% of kidney replacement therapy (KRT) while peritoneal dialysis (PD) utilization stays low at approximately 9 to 10% despite its potential advantages in cost and lifestyle benefits. The region records high kidney transplantation rates which reach 20.2 per million population (pmp) in Saudi Arabia through the support of Saudi Center for Organ Transplantation (SCOT). The Saudi healthcare system has achieved important progress. The Ministry of Health (MOH) together with other government sectors operates most dialysis centers while the private sector continues to expand its participation. The 2022 Saudi Guideline for Chronic Kidney Disease developed through GRADE-ADOLOPMENT methodology provides guidelines for blood pressure management and kidney replacement therapy (KRT) modalities using localized context.6 The Health Sector Transformation Program of Saudi Vision 2030 creates a historic opportunity for nephrology advancement through its emphasis on prevention and primary care strengthening and digital health implementation and value-based care development.7 The existing obstacles continue to hinder progress because people present to treatment after their conditions become severe and different regions face different levels of chronic kidney disease which affects southern areas more than other parts and patients show low interest in peritoneal dialysis while doctors distribute their workforce inefficiently and medical facilities lack proper adoption of new diagnostic tools and treatment methods.8 The review investigates present kidney disease treatment methods to discover major obstacles which need to be addressed through advanced solutions that will create substantial improvements in nephrology results. Review Materials and Methods Search Strategy The systematic literature review used systematic literature search methods in adherence to the guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) to achieve its goal of complete coverage.9 A comprehensive search was performed across four electronic databases: PubMed, Web of Science, Scopus, Google Scholar and Saudi-specific repositories.10 Search terms were constructed using Boolean operators and Medical Subject Headings (MeSH) terms where applicable. The keywords included “ kidney disease” “chronic kidney disease” “dialysis” “kidney transplantation” “nephrology” “Saudi Arabia” “Vision 2030” “biomarkers” “artificial intelligence” combined using Boolean operators such as such as “AND” and “OR” to refine results. Synonyms and related terms (eg, “chronic kidney disease,” “acute kidney injury,” “Vision 2030”) were also incorporated to ensure comprehensiveness. Figure 1 represents the study selection process. The PRISMA flowchart represents the study selection process. Abbreviation: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The King Saud University Institutional Review Board (E-25-4567) and local committees granted ethical approval for the study. Inclusion and Exclusion Criteria The inclusion criteria required original studies and review articles along with guidelines and reports as these study types offer high-quality evidence for evaluating the effectiveness which examined the epidemiology and management of kidney disease in Saudi Arabia and the Gulf region. The researchers eliminated articles that were written in languages other than English and those that had no connection to the study topic. Cohort and observational studies were excluded to maintain consistency in study quality and to mitigate biases inherent to non-randomized designs. The population of interest comprised human subjects diagnosed with Chronic Kidney Disease or Acute kidney disease. Additionally, studies were required to include a defined control group, such as a placebo or standard of care. Two reviewers screened the titles and abstracts plus the complete texts independently while they reached an agreement to solve any differences. The research study recognized 312 records as registers as valid sources plus 357 from Databases. The research team evaluated 87 full-text articles after removing duplicates or ineligible by automation tools or any other reason and completing the screening process. The synthesis used 68 sources as evidence, with 30 essential references serving as key citations. The researchers extracted data about prevalence rates and risk elements and KRT treatment methods and workforce data and obstacles and innovation implementation. Studies were excluded if they did not involve human subjects, reported inadequate or incomplete data, or failed to meet the methodological standards for randomized analysis. This strict inclusion and exclusion framework was designed to ensure that the review synthesized the most reliable and relevant evidence. Data Extraction The initial search yielded a total of 312 studies, of which 30 met the inclusion criteria after screening and full-text review. Two researchers independently reviewed the studies for relevance and quality. In cases of disagreement, a third researcher was consulted, and inter-rater reliability was calculated using kappa statistics (indicating substantial agreement). Data extracted from each study included the study design, number of participants, parameters assessed, details, control group characteristics, follow-up duration, and key findings. Table 1 provides a summary of the selected studies. Table 1Summary of Studies on Kidney DiseaseStudy/ReferenceYearDesignPopulation/SettingKey FindingsLimitationsAlshehri et al22025Cross-sectional (lab network)Nationwide, 691,388 tests, 13 regionsCKDprevalence 4.76%; stage 3: 3.5%; higher in males and elderly; geographic variation (Makkah/Jazan higher)Laboratory-based; may miss undiagnosed casesMousa et al32021Famiy screening>5000 first-degree relatives of dialysis patientsCKDprevalence 13.8%; higher in southern regionHigh-risk population; not generalizableAyman Karkar et al52025Descriptive (registry)Nationwide KRT 202128,509 on KRT(HD 20,534, PD1861,transplant 6114); HDdominant; diabetes 42%,HTN 34%Snapshot data; limited longitudina l outcomesAlhasan et al62022/2024Guideline(GRAE-ADOLOPM ENT)Adults & children with CKDRecommendatio ns on BP control, RASi, KRT timing and modalityAdapted from KDIGO;local data integration variableVachharajaniet al112021Observationa l (GCC)GCC countries incl. KSANephrologist density 39 pmp in KSA; HD dominantRegional comparison; training gaps notedAlobaidi et al122025Narrative reviewSaudi & internationalNovel biomarkers, multi-omics, AI for early detectionNot primary data; synthesis- focusedDahlan et al132016SurveyNephrologists in KSAPD underutilization (9%); barriers: training, motivation, infrastructureAbbreviations: CKD, Chronic kidney disease; KRT, kidney replacement therapy; HD, Hemodialysis; PD, Peritoneal dialysis; HTN, Hypertension; RASi, Renin-Angiotensin System inhibitors; KDIGO, Kidney Disease, Improving Global Outcomes GCC, Gulf Cooperation Council; KSA, Kingdom of Saudi Arabia; pmp, per million population; AI, artificial intelligence. Summary of Studies on Kidney Disease Abbreviations: CKD, Chronic kidney disease; KRT, kidney replacement therapy; HD, Hemodialysis; PD, Peritoneal dialysis; HTN, Hypertension; RASi, Renin-Angiotensin System inhibitors; KDIGO, Kidney Disease, Improving Global Outcomes GCC, Gulf Cooperation Council; KSA, Kingdom of Saudi Arabia; pmp, per million population; AI, artificial intelligence. Quality Assessment Table 1 provides a quality assessment of studies included in this systematic review, each evaluating various aspects of Kidney diseases. The studies encompass a range of designs, including either Guideline (GRAE-ADOLOPM ENT) and/or randomized controlled trials (RCTs) and/or systematic reviews and/or meta-analyses, Cross-sectional (lab network), observational studies, survey, and narrative reviews. Quality assessment tools were selected based on study design to ensure a comprehensive evaluation of methodological rigor and relevance. These evaluations are crucial for interpreting the overall quality and applicability. Results Diabetes and hypertension account for the majority of CKD/ESKD cases. The study found 34.3% of patients had diabetic nephropathy and 20.9% had hypertensive nephropathy.5 The study showed that proteinuria and reduced eGFR appeared as common problems which different geographical areas exhibited in southern regions with higher combined CKD prevalence.2 The research found that more than 1900 HD machines used to treat multiple patients while current estimates show that more than 20,000 people undergo dialysis treatment today.5 Most units operate from hospitals while the MOH and external providers handle most healthcare needs. The medical field uses bicarbonate dialysis as its main treatment method and healthcare facilities are starting to use online Hemodiafiltration (HDF).5 SCOT manages kidney transplantation through its living donor and deceased donor programs.14 The incidence rate in Saudi Arabia reaches 20.2 pmp which ranks among the highest rates in the Gulf Cooperation Council (GCC).11 The culture and logistical challenges together with the insufficient number of donors now stop development from continuing. Workforce Data and Outcomes The number of nephrologists has grown significantly through the years because current estimates show 1279 nephrologists work in Saudi Arabia while the total number of nephrologists in the Gulf Cooperation Council nations reaches 1686. The system demonstrates better distribution than most low- and middle-income countries because it maintains better service throughout its territory yet most services remain concentrated in urban areas. The organization maintains different staff ratios for nurses and dietitians and social workers because they require continuous professional development. Dialysis facilities have grown through extensive infrastructure development. Guideline Adherence and Management The 2022 Saudi CKD Guideline establishes evidence-based blood pressure targets which require renin-angiotensin system blockage and personalized kidney replacement therapy selection.15 The existing early detection programs only reach high-risk populations according to current implementation in various locations. Challenges in Clinical Translation to Optimal Care The optimal management of kidney disease faces multiple obstacles which exist at three different management levels. Patients with advanced disease present themselves for treatment at later times which leads to worse results because they miss their needed medical care. Peritoneal dialysis (PD) utilization remains critically low because 9 to 10% of dialysis patients receive PD treatment.13 The situation exists because patients and providers prefer different things and training programs lack necessary content and medical facilities lack essential resources. The process of transplantation requires doctors to overcome multiple financial and logistical challenges which include the problem of having limited donor resources that 40.5% of survey participants identified through their feedback. The combination of regional differences and insufficient conservative kidney treatment methods creates more difficulties for doctors who treat patients in these areas. Rural areas experience two major problems which include a lack of medical staff and irregular access to teams of specialists who provide treatment. The physicians who treat chronic kidney disease (CKD) patients face minimal obstacles which they must overcome during their work. The view of the problem shows that because patients must pay high out-of-pocket medical expenses for extra services they need to spend more money which creates a heavy burden. The national CKD registries have not been established yet which prevents the organization from improving quality through data analysis.16 The existing gaps between perception and reality need to be closed through specific strategies which include early patient referrals and development of professional development training programs and infrastructure and donor initiatives and distribution of resources and establishment of strong registries. Bridging the Gap Between Perception and Reality Saudi Arabia possesses excellent capabilities to implement new technologies that improve kidney care services. The introduction of Neutrophil gelatinase-associated lipocalin (NGAL) and Kidney injury molecule-1 and 2, (KIM-1 and TIMP-2-) Insulin-like growth factor-binding protein 7 (IGFBP7) and cystatin C and multi-omics panels as novel biomarkers enables medical professionals to identify kidney disease at an earlier stage. Artificial intelligence together with predictive analytics which uses machine learning models delivers effective methods for risk assessment and disease progression prediction and customized treatment plans for patients with diabetic kidney disease and those in critical care nephrology environments.5 Telemedicine and remote monitoring solutions function as complete systems that benefit peritoneal dialysis patients and rural areas because some healthcare centers use remote PD monitoring to improve patient access and treatment compliance. The research focuses on hybrid medicine and innovative treatment methods through the combination of genetic data and inflammatory markers and designated disease treatment drugs which include Sodium-Glucose Co-Transporter-2 inhibitor (SGLT2 inhibitors) and Glucagon-Like Peptide-1 receptor agonist (GLP-1 agonists) and non-steroidal mineralocorticoid receptor antagonists. The implementation of specific programs will enable healthcare facilities to provide more peritoneal dialysis and home hemodialysis treatment options which will result in decreased medical expenses and enhanced patient well-being. The Vision 2030 initiatives establish the foundational policies which enable the growth of two particular innovations through their implementation of the “Taakad” preventive screening program and their digital health transformation efforts. Future Directions for a Giant Leap To achieve its healthcare objectives for Vision 2030 Saudi Arabia needs to implement comprehensive strategies which will treat chronic kidney disease (CKD) through every phase of treatment beginning with prevention and continuing through advanced medical intervention. The foundation of this transformation will be established through the introduction of a nationwide screening program which will evaluate CKD risks through screening and risk assessment tests. The project will use basic test results which include estimated glomerular filtration rate (eGFR) and albuminuria to identify high-risk patients through advanced AI-powered systems.12 The mobile screening units will operate in primary care clinics and workplaces and community centers through smartphone apps which provide immediate risk assessments. AI algorithms which learned from local datasets achieved more than 90% accuracy in predicting disease progression which similar programs demonstrated through their deployment in the National Health Service (NHS) Kidney Health Checks system.12 The program will combine with the “Taakad” preventive screening framework to evaluate multiple millions of patients each year while categorizing them into three risk groups for specific treatment approaches. The program prevents a 20–30% increase in end-stage kidney disease (ESKD) cases while generating substantial financial savings because early detection decreases dialysis requirements by 50% which enables resource allocation toward new developments. The first step to prevent diseases leads to home healthcare transformation through increased peritoneal dialysis (PD) usage which needs to reach at least 20–25%. The current PD usage across many regions shows less than 10% adoption because this treatment method provides better life quality and flexible scheduling and reduced infection hazards when compared to in-center hemodialysis.12 The organization needs to implement nationwide training systems which educate both nurses and patients through digital teaching methods and WhatsApp patient information programs to reach its objective. The monitoring solution would protect patient safety through remote technologies which include wearable sensors for fluid status evaluation and telehealth applications which provide daily patient contact. The Riyadh and Jeddah pilot programs will establish operational procedures that Australian home setups use to achieve 25% peritoneal dialysis rates through their subsidized program.17 The implementation of this shift will help decrease hospital congestion which results in 30–40% annual savings for each patient while giving all patients the ability to receive treatment at home, especially women and residents of rural areas, which supports the objectives of digital health transformation.18 The field of transplantation needs to grow through its two main goals which involve increasing living and deceased donor rates by implementing more efficient procedures and raising public knowledge about the process. The current progress of donor matching together with waitlist management systems faces obstacles because of administrative requirements which should be resolved through the establishment of a national transplant registry that uses artificial intelligence to match patients with organ donors. Public campaigns, which use TikTok influencers together with Seha app partnerships, will educate people about donation myths, which will increase donation consent rates in the same way that Spain achieves 40+ donor agreements for every million people. The system needs to provide priority healthcare access for donor families because this incentive will make more people participate in organ donation which will result in thousands of additional transplants every year while decreasing dialysis needs.19 Developing the nephrology workforce requires equal investment to achieve success. The hospital should develop fellowships to train healthcare professionals in three core areas: interventional nephrology, transplantation surgery, and artificial intelligence (AI) skills. The annual target should establish 500 new nephrologists who will complete essential digital training to resolve the existing deficit of nephrologists, which stands at one for every 100,000 people.19 The complete integration of biomarkers and digital health tools into electronic health records systems will become possible through the expedited development of a national health registry system. The formation of multidisciplinary teams, which includes nephrologists and dietitians along with psychologists and data analysts, will lead to better results through their work in value-based healthcare systems. The healthcare system achieves cost-effective solutions through its reimbursement system for bundled payments, which ties reimbursement to hospitalization rates and patient-reported outcomes. The combined recommendations create a major advance that will decrease CKD mortality by 50% while creating billions in savings before the year 2030. Discussion The current kidney disease treatment system in Saudi Arabia establishes a strong basis for healthcare delivery through its advanced medical facilities which include King Faisal Specialist Hospital and its extensive dialysis network that operates for more than 20000 patients and its cutting-edge organ transplant program which functions at the Saudi Center for Organ Transplantation (SCOT). The Ministry of Health (MOH) has implemented the National Program for Chronic Non-Communicable Diseases which includes CKD screening pilot programs while Seha platform electronic health records enable basic data monitoring. Dialysis services expanded consistently as hemodialysis facilities established presence in distant locations and annual living donor transplants reached almost 500.20 The organization demonstrates its dedication to quality through its operational achievements which achieve global standards for survival rates and its successful implementation of home hemodialysis trials. Nephrology needs faster progress and development of fair reforms to achieve the universal health coverage and digital transformation and economic growth targets which Vision 2030 establishes. The situation demands an immediate major change because CKD impacts 15 to 20% of adults and diabetes causes 60% of ESKD cases and people face different access challenges between regions and there are not enough healthcare workers available. The essential progress toward this leap requires the elimination of crucial obstacles that impede development. Geographic inequities force rural patients from the Eastern Province and Asir region to spend multiple hours traveling for dialysis treatment which leads to increased medical complications and financial burdens. Limited educational resources together with insufficient infrastructure development create cultural stigmas that prevent people from undergoing transplantation procedures and cause less than 10% of patients to adopt PD treatment. The economic situation faces increasing pressure because yearly dialysis expenses for each patient exceed SAR 50000 and this amount will increase through time as the population ages and obesity rates rise. The local Saudi population needs specific guidelines which will address their unique genetic risks from APOL1 variants and typical Gulf population inflammation markers.21 The new updated protocols, which Saudi Society of Nephrology developed together with other organizations, require primary care facilities to use AI-based risk assessment tools that meet international standards and use local healthcare data. New technologies provide the necessary power which drives this significant advancement. The EMPA-KIDNEY trials demonstrate that precision medicine which combines genomics data with SGLT2 inhibitors and GLP-1 agonists will stop CKD progression for 30–40% of diabetic patients. The remote monitoring solution through wearables and applications will enable more people to perform home dialysis, which will result in increased peritoneal dialysis usage to 20–25% while reducing hospital stays by 50% and giving patients more control over their treatment.22 Nephrology students who complete AI literacy training will learn how to use predictive analytics for graft survival assessment, while national registries that use block chain technology will improve donor matching efficiency. Digital twins use virtual patient models to create therapy simulations, which enable customized treatment solutions and decrease the need for multiple test procedures. The “Taakad” screening and digital health elements of Vision 2030 create the framework which allows mobile units to perform eGFR and albuminuria tests throughout the country, which can potentially stop 100,000 ESKD cases by 2030.23 The main objective of kidney replacement therapy (KRT) needs proper optimization which requires a resource-based assessment that compares current hemodialysis practices with a system that includes 25% peritoneal dialysis and 15% home hemodialysis and double the number of yearly transplants to 1000. The SCOT process improvements together with TikTok public awareness campaigns and living donor tax incentives will help accomplish this goal. Multidisciplinary teams need nephrologists and endocrinologists and psychologists and data scientists to establish patient-centered outcomes which medical professionals must evaluate through quality-adjusted life years (QALYs) instead of survival rates. The value-based care models provide reimbursement based on progression-free survival and satisfaction score metrics which leads to operational efficiency. The foundation of successful projects requires ongoing cooperative efforts. The Ministry of Health should establish policy directions while SCOT handles transplant operations and SSN develops training standards and King Saud University leads research efforts and Dr. Sulaiman Al Habib operates as a private sector technology investor. Public-private partnerships will finance workforce development initiatives which involve training 1000 specialists in interventional nephrology AI and precision therapies through a SAR 5 billion investment while international partnerships with the NKF and ERA will deliver best practices. Saudi Arabia can achieve three objectives through strategic investment which requires allocating 1–2% of its SAR 300 billion health budget. The Kingdom now establishes itself as the leading regional authority for precise nephrology and preventive kidney care through its advanced medical research capabilities which it shares with the Gulf Cooperation Council countries and other regions. The giant leap is within reach: bold action today ensures a healthier tomorrow. Conclusions Saudi Arabia has substantially expanded its dialysis and kidney transplantation capacity; however, available evidence indicates persistent regional disparities, limited adoption of home-based kidney replacement therapies, and important gaps in national kidney disease surveillance systems. Strengthening standardized CKD screening strategies, improving patient education regarding treatment modalities, optimizing nephrology workforce distribution, and establishing comprehensive national registries represent evidence-based priorities for future healthcare improvement. Nevertheless, additional prospective and nationally representative studies are required to determine the measurable impact of emerging digital health technologies, artificial intelligence, and precision medicine approaches on kidney disease outcomes. Funding Statement The author of this manuscript declares that there was no funding for this research. Data Sharing Statement The author declares that all the data and materials are available. Ethics Approval and Consent to Participate The King Saud University Institutional Review Board (E-25-4567) and local committees granted ethical approval for the study. The ethics of this research was done in accordance with the Declaration of Helsinki. Consent for Publication Consent for publication was granted. Disclosure No competing interests. References Associated Data Data Availability Statement The author declares that all the data and materials are available.